Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb, Cobenfy
Bristol-Myers Stock Jumps on FDA Approval for New Schizophrenia Drug
Shares in Bristol-Myers Squibb (BMY) surged Friday, after the Food and Drug Administration approved the drugmaker's novel treatment for schizophrenia. Bristol-Myers shares stood about 6% higher in recent premarket trading,
Cobenfy Approval Brings 20% Upside To Bristol Myers Squibb Stock
This is a big approval for the company, given that Cobenfy doesn’t have the classic side effects seen in other antipsychotic drugs.
Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)
Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving revenue. Read my update on BMY stock.
4h
Solihull Food Festival 2024 full line-up with celebrity chefs, live music and more
Spectators can look forward to live cookery shows by famed chefs Glynn Purnell and Aldo Zilli, while the fan-favourite Rum ...
1h
on MSN
Bristol Cobenfy approval draws optimism from Street, though with caveats
The U.S. FDA's approval Thursday of Bristol Myers Squibb's (NYSE:BMY) novel antipsychotic Cobenfy (xanomeline and trospium ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Promotes watch collection
Pleads not guilty
'Harry Potter' star dies
Stadiums to serve as shelters
World's oldest cheese found
Targeted Black residents?
Killer gets life sentence
50/50 ball ownership suit
Producing doc on Diddy
Ending password-sharing
Boxes to distribute Narcan
Urgent safety alert for 737s
WI duplicate ballot flap
Heads to US-Mexico border
On Secret Service failures
Capital goods orders up
Fake Biden robocalls fine
Chinese submarine sank
More executives leave
NC board removes 747K
NIH finds misconduct
ISR targets Hezbollah HQ
US charges three Iranians
Related topics
Bristol Myers Squibb
schizophrenia
Food and Drug Administration
Karuna Therapeutics
Coventry
Feedback